Medical and Pharmaceutical Eli Lilly inks USD$2.75B AI drug deal with Insilico Medicine Insilico has developed at least 28 drug candidates using generative AI tools Joseph Morton4 hours ago
Sleep Epilepsy drug reduces sleep apnea symptoms by up to 50 per cent in clinical trial Sleeping with a noisy breathing machine remains one of the biggest frustrations for people with obstructive sleep apnea. However, researchers said an older epilepsy... Joseph MortonMarch 13, 2026
AI and Autonomy Illumina partners with pharma giants to map disease biology at unprecedented scale Those models should help Merck develop virtual cell systems that better predict which diseases drugs may treat Joseph MortonJanuary 15, 2026
Medical and Pharmaceutical AI-powered lung cancer detection debuts at Topeka’s St. Francis Hospital The program aims to prevent overlooked findings, surface patients who need additional review, and support long-term monitoring Joseph MortonSeptember 10, 2025
Health & Wellness Akero Therapeutics nearly doubles stock price on positive clinical studies MASH is a more severe form of metabolic dysfunction-associated steatotic liver disease formerly known as non-alcoholic fatty liver disease Joseph MortonJanuary 27, 2025
Health & Wellness Vivos Therapeutics new device could provide substantial relief for migraine sufferers The device works by gently repositioning the lower jaw to help open up the airway Joseph MortonMay 2, 2023